
Abstract Cholestasis is a pathological condition characterized by impaired bile flow. Key events contributing to cholestatic liver injury can be categorized into an adverse or an adaptive response, with both closely linked to changes in the bile acid pool. In this regard, the intracellular accumulation of bile acids is considered an essential and central key event within the adverse outcome pathway. A systematic understanding of bile acid profiles in vitro is of critical importance for advancing insights into the mechanistic complexity of cholestasis, and for supporting the informed development and application of human-relevant new approach methodologies. This study aimed to document bile acid profiles reported in simple human 2D and 3D hepatic in vitro models across temporal, spatial, and contextual dimensions. A dataset was compiled based on a systematic PubMed search including peer-reviewed research articles reporting in vitro bile acid concentrations across studies, cell models, cellular locations, and bile acid species. Quantitative treatment effects were assessed using log2-transformed treated-to-control ratios and visualized as heatmaps. Primary human hepatocytes, and human hepatoma cell lines HepaRG® and HepG2, were utilized to a comparable extent and conjugated bile acids were most frequently assessed. Patterns identified following chemical exposure were broadly consistent with the AOP framework and may have relevance as mechanistic markers. However, the fragmented and heterogeneous nature of the available data hampers precise and comprehensive identification of consistent patterns within specific experimental scenarios, indicating that a substantially larger body of evidence is needed together with the standardization of analytical procedures for bile acid quantification.
Abstract Florfenicol (FF) is an antibiotic used for treating respiratory disease in food animals. Extralabel use of FF may lead to violative residues of FF and its major metabolite florfenicol amine (FFA) in edible tissues. This study aimed to develop a physiologically based pharmacokinetic (PBPK) model to predict FF and FFA concentrations in edible tissues of sheep to estimate extralabel withdrawal intervals (WDIs). The model consisted of two flow-limited sub-models for FF and FFA. The model was calibrated with FF plasma and FFA tissue concentration data. Upon calibration, the model was evaluated with independent datasets from the Food Animal Residue Avoidance Databank (FARAD). The determination coefficient (R2) values for the goodness-of-fit analysis were 0.97 and 0.93 for model calibration and evaluation datasets, respectively. Furthermore, a population PBPK model was developed using Monte Carlo sampling to estimate the time required for 99th percentile concentration estimates to decline to levels below a given threshold tolerance level associated with safe consumption. Finally, the model was converted into an interactive PBPK (iPBPK) web interface using R Shiny to facilitate the model application. This modeling framework provides a useful tool for predicting WDIs for FF after extralabel use in sheep to support food safety assessment.
Abstract Fourth generation (4th-gen) electronic nicotine delivery systems (ENDS) are increasingly popular among U.S. youth, yet little is known about the pulmonary effects of nicotine-rich ENDS aerosols during adolescence. We investigated the long-term impact of ENDS aerosols from third generation (3rd-gen) and 4th-gen devices on lung structure, function, and biochemical responses in juvenile male and female mice. Beginning at 4-6 weeks of age, mice were whole-body exposed to either air, tobacco-flavored 3rd-gen ENDS aerosols containing 24 mg/mL free base nicotine, or tobacco-flavored 4th-gen ENDS aerosols containing 24 mg/mL nicotine salt, for 1 hr/day over 3 months. Exposures were performed at similar aerosol particle size distributions (∼274 nm median size) and total particulate matter concentrations (∼0.4 mg/puff). Despite comparable exposure levels, we found that free base nicotine (3rd-gen ENDS) induces more severe airway remodeling than nicotine salts (4th-gen ENDS) in juvenile mice, as evidenced in males by significantly increased collagen deposition, persistent restrictive lung function, pulmonary macrophage infiltration, and upregulation of fibrosis- and inflammation-related genes, corroborating lung structural and functional changes. Both ENDS exposures significantly increased mean linear intercepts, indicating altered lung architecture. In contrast, nicotine salts produce milder lung function effects despite the enhanced serum cotinine bioavailability. These findings demonstrate differential pulmonary toxicity of ENDS aerosols by nicotine chemical form. Also, sex-specific patterns emerged, with male mice showing greater adverse pulmonary responses to ENDS aerosols compared to female mice. Together, our results highlight that youth vaping may alter respiratory health trajectory and increase susceptibility for lung diseases.
Abstract Background Recovery from acute hepatotoxic injury (AHTI), including drug-induced liver injury, is conventionally defined by normalization of serum biomarkers and resolution of clinical and histopathological abnormalities. However, biochemical normalization may not reflect structural and functional restitution of the hepatic microenvironment. Methods This hypothesis-driven narrative review brings together findings from experimental and translational evidence on molecular and cellular alterations persisting after AHTI. It distinguishes established findings from proposed mechanisms and long-term consequences, emphasizing limitations in evidence regarding clinical significance. Results Emerging studies demonstrate that molecular, cellular, and spatial alterations may persist after serum biomarkers normalize. Regeneration driven by oxidative stress, replicative demand, metabolic rewiring, and developmental pathway reactivation restores tissue mass but may reshape clonal dynamics and leave spatially restricted molecular imprints. These alterations involve hepatocytes and non-parenchymal cells, including hepatic stellate cells, macrophages, and endothelial cells. Whether persistent signatures reflect adaptive remodeling, delayed resolution, or stable scarring remains unclear. Although clinical evidence has not established whether resolved AHTI alters susceptibility to a subsequent "second hit," incomplete molecular resolution challenges definitions of hepatic resilience. Current findings derive predominately from intrinsic toxicity models and should not be extrapolated across etiologies without direct comparison. Conclusion Persistent molecular scars suggest that biochemical normalization does not indicate complete hepatic recovery. Integrating spatial and single-cell modalities into toxicology frameworks may improve post-injury monitoring, identify biomarkers of resolution, and inform regulatory safety standards. Because human liver tissue is rarely accessible for these analyses, clinical translation will likely require minimally invasive approaches, including circulating biomarkers and extracellular vesicles.
Di(2-ethylhexyl) phthalate (DEHP) is one of the most studied phthalates due to its high occurrence and toxicity. Diisononyl phthalate (DiNP) is a replacement chemical for DEHP. However, little was known about the effects of DEHP and DiNP exposure on white and brown adipose tissue (WAT and BAT). Thus, we tested the hypothesis that chronic exposure to DEHP and DiNP disrupts WAT and BAT morphology, and the expression of adipogenic, inflammatory, oxidative stress, and apoptosis factors in WAT and BAT from female mice. Female CD-1 mice were fed vehicle control, DEHP, or DiNP at 0.15 ppm (daily human exposure), 1.5 ppm (occupational exposure) and 1500 ppm (above typical human exposure) through the chow for 6 months. Both DEHP and DiNP exposure increased crown-like structure (CLS) number and led to changes in expression of adipogenesis genes in WAT. In addition, DiNP increased expression of antioxidant markers and c-Myc + cell (M2 macrophage marker) numbers. DEHP decreased apoptosis markers and mast cell numbers in WAT. In contrast, DEHP and DiNP exposure led to changes in expression of metabolic, inflammatory, and collagen genes that contributed to an increase in adipocyte droplet number, reduced CD38 + cells (M1 macrophage marker) and c-Myc + cells, and reduced collagen deposition in BAT. Collectively, data from this study show that chronic DEHP and DiNP exposure changes WAT and BAT morphology and gene expression related to adipogenesis, inflammation, and oxidative stress expression markers in female mice.